NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway

Glioblastoma (GBM) is one of the most lethal primary brain tumor with a poor median survival less than 15 months. Despite the development of the clinical strategies over the decades, the outcomes for GBM patients remain dismal due to the strong proliferation and invasion ability and the acquired res...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Jianyang, Alafate, Wahafu, Wu, Wei, Wang, Yichang, Li, Xiaodong, Xie, Wanfu, Bai, Xiaobin, Li, Ruichun, Wang, Maode, Wang, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760305/
https://www.ncbi.nlm.nih.gov/pubmed/35031599
http://dx.doi.org/10.1038/s41419-022-04512-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760305/
https://www.ncbi.nlm.nih.gov/pubmed/35031599
http://dx.doi.org/10.1038/s41419-022-04512-6

Ejemplares similares